Level 2, Building 77
Monash University Clayton
Phone: +61 3 9902 9323
This facility provides expert mass spectrometry services for identifying proteins, quantifying levels of expression and sequencing.
The proteomics approach enables abundant proteins to be removed so that focus can be directed to the low expressing proteins that are potential novel markers of disease, or targets for therapy.
Key assets include the Applied Biosystems 4700 Proteomics Discovery System (MALDI-TOF-TOF) for protein identification and mass fingerprinting, the Capillary LC and HCT Ultra Ion Trap for protein identification and post translational analysis, the Nano LC and Micro TOF/q system for high accuracy mass spectrometry and quantification, and the Applied Biosystems Procise Protein Sequencer for N-terminal sequencing of picomole quantities of protein or peptide.
Research Facilities and Platforms
Biomedical Proteomics Facility
Cancer Trials Australia
Centre for Drug Candidate Optimisation (CDCO)
Gandel Trust Sequencing Facility
High Throughput Protein Production Facility
Monash Antibody Technologies Facility (MATF)
Monash Biomedical Imaging Facility
Monash Histology Platform
Monash Micro Imaging
Prostate Cancer Registry
Southern Health Tissue Bank
Victorian Melanoma Service